Furthermore, we show in a mouse xenograft model of colorectal cancer that the novel bi-specific VEGF/Ang2 blocking nanobody BI-880 diminished neutrophil infiltration associated with anti-VEGF treatment and efficiently reduced tumour growth and hypoxia. This evidence concerns the gene VEGFA and colorectal cancer.